{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:27:37Z","timestamp":1793831257503,"version":"4.6.1"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T00:00:00Z","timestamp":1673568000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T00:00:00Z","timestamp":1673568000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100019180","name":"HORIZON EUROPE European Research Council","doi-asserted-by":"publisher","award":["H2020-ERC-2017-ADV-788982-COLMIN"],"award-info":[{"award-number":["H2020-ERC-2017-ADV-788982-COLMIN"]}],"id":[{"id":"10.13039\/100019180","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003246","name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["VI.Veni.192.094"],"award-info":[{"award-number":["VI.Veni.192.094"]}],"id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Basic Res Cardiol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Following an acute myocardial infarction, reperfusion of an occluded coronary artery is often accompanied by microvascular injury, leading to worse long-term prognosis. Experimental studies have revealed the potential of tyrosine-kinase inhibitor imatinib to reduce vascular leakage in various organs. Here, we examined the potential of imatinib to attenuate microvascular injury in a rat model of myocardial reperfusion injury. Isolated male Wistar rat hearts (<jats:italic>n<\/jats:italic>\u2009=\u200920) in a Langendorff system and male Wistar rats (<jats:italic>n<\/jats:italic>\u2009=\u200937) in an in vivo model were randomly assigned to imatinib or placebo and subjected to ischaemia and reperfusion. Evans-blue\/Thioflavin-S\/TTC staining and Cardiac Magnetic Resonance Imaging were performed to assess the extent of reperfusion injury. Subsequently, in vivo hearts were perfused ex vivo with a vascular leakage tracer and fluorescence and electron microscopy were performed. In isolated rat hearts, imatinib reduced global infarct size, improved end-diastolic pressure, and improved rate pressure product recovery compared to placebo. In vivo, imatinib reduced no-reflow and infarct size with no difference between imatinib and placebo for global cardiac function. In addition, imatinib showed lower vascular resistance, higher coronary flow, and less microvascular leakage in the affected myocardium. At the ultrastructural level, imatinib showed higher preserved microvascular integrity compared to placebo. We provide evidence that low-dose imatinib can reduce microvascular injury and accompanying myocardial infarct size in a rat model of acute myocardial infarction. These data warrant future work to examine the potential of imatinib to reduce reperfusion injury in patients with acute myocardial infarction.<\/jats:p>","DOI":"10.1007\/s00395-022-00974-z","type":"journal-article","created":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T18:03:13Z","timestamp":1673632993000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Imatinib attenuates reperfusion injury in a rat model of acute myocardial infarction"],"prefix":"10.1007","volume":"118","author":[{"given":"Lara S. F.","family":"Konijnenberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom T. J.","family":"Luiken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andor","family":"Veltien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laween","family":"Uthman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolien T. A.","family":"Kuster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Rodwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guus A.","family":"de Waard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariska","family":"Kea-te Lindert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anat","family":"Akiva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dick H. J.","family":"Thijssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Nijveldt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6136-8640","authenticated-orcid":false,"given":"Niels","family":"van Royen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,13]]},"reference":[{"key":"974_CR1","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1165\/rcmb.2010-0371OC","volume":"45","author":"K Abe","year":"2011","unstructured":"Abe K, Toba M, Alzoubi A, Koubsky K, Ito M, Ota H, Gairhe S, Gerthoffer WT, Fagan KA, McMurtry IF, Oka M (2011) Tyrosine kinase inhibitors are potent acute pulmonary vasodilators in rats. Am J Respir Cell Mol Biol 45:804\u2013808. https:\/\/doi.org\/10.1165\/rcmb.2010-0371OC","journal-title":"Am J Respir Cell Mol Biol"},{"key":"974_CR2","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1007\/s10456-021-09781-x","volume":"24","author":"J Amado-Azevedo","year":"2021","unstructured":"Amado-Azevedo J, van Stalborch AD, Valent ET, Nawaz K, van Bezu J, Eringa EC, Hoevenaars FPM, De Cuyper IM, Hordijk PL, van Hinsbergh VWM, van Nieuw Amerongen GP, Aman J, Margadant C (2021) Depletion of Arg\/Abl2 improves endothelial cell adhesion and prevents vascular leak during inflammation. Angiogenesis 24:677\u2013693. https:\/\/doi.org\/10.1007\/s10456-021-09781-x","journal-title":"Angiogenesis"},{"key":"974_CR3","doi-asserted-by":"publisher","first-page":"2728","DOI":"10.1161\/circulationaha.112.134304","volume":"126","author":"J Aman","year":"2012","unstructured":"Aman J, van Bezu J, Damanafshan A, Huveneers S, Eringa EC, Vogel SM, Groeneveld AB, Vonk Noordegraaf A, van Hinsbergh VW, van Nieuw Amerongen GP (2012) Effective treatment of edema and endothelial barrier dysfunction with imatinib. Circulation 126:2728\u20132738. https:\/\/doi.org\/10.1161\/circulationaha.112.134304","journal-title":"Circulation"},{"key":"974_CR4","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/s41573-021-00252-y","volume":"20","author":"MM Attwood","year":"2021","unstructured":"Attwood MM, Fabbro D, Sokolov AV, Knapp S, Schi\u00f6th HB (2021) Trends in kinase drug discovery: targets, indications and inhibitor design. Nat Rev Drug Discov 20:839\u2013861. https:\/\/doi.org\/10.1038\/s41573-021-00252-y","journal-title":"Nat Rev Drug Discov"},{"key":"974_CR5","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1148\/radiol.2021204265","volume":"301","author":"CWH Beijnink","year":"2021","unstructured":"Beijnink CWH, van der Hoeven NW, Konijnenberg LSF, Kim RJ, Bekkers S, Kloner RA, Everaars H, El Messaoudi S, van Rossum AC, van Royen N, Nijveldt R (2021) Cardiac MRI to visualize myocardial damage after ST-segment elevation myocardial infarction: a review of its histologic validation. Radiology 301:4\u201318. https:\/\/doi.org\/10.1148\/radiol.2021204265","journal-title":"Radiology"},{"key":"974_CR6","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/nrcardio.2014.188","volume":"12","author":"RP Betgem","year":"2015","unstructured":"Betgem RP, de Waard GA, Nijveldt R, Beek AM, Escaned J, van Royen N (2015) Intramyocardial haemorrhage after acute myocardial infarction. Nat Rev Cardiol 12:156\u2013167. https:\/\/doi.org\/10.1038\/nrcardio.2014.188","journal-title":"Nat Rev Cardiol"},{"key":"974_CR7","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s00395-018-0696-8","volume":"113","author":"HE B\u00f8tker","year":"2018","unstructured":"B\u00f8tker HE, Hausenloy D, Andreadou I, Antonucci S, Boengler K, Davidson SM, Deshwal S, Devaux Y, Di Lisa F, Di Sante M, Efentakis P, Femmin\u00f2 S, Garc\u00eda-Dorado D, Giricz Z, Ibanez B, Iliodromitis E, Kaludercic N, Kleinbongard P, Neuh\u00e4user M, Ovize M, Pagliaro P, Rahbek-Schmidt M, Ruiz-Meana M, Schl\u00fcter KD, Schulz R, Skyschally A, Wilder C, Yellon DM, Ferdinandy P, Heusch G (2018) Practical guidelines for rigor and reproducibility in preclinical and clinical studies on cardioprotection. Basic Res Cardiol 113:39. https:\/\/doi.org\/10.1007\/s00395-018-0696-8","journal-title":"Basic Res Cardiol"},{"key":"974_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23042282","author":"J Bouitbir","year":"2022","unstructured":"Bouitbir J, Panajatovic MV, Kr\u00e4henb\u00fchl S (2022) Mitochondrial toxicity associated with imatinib and sorafenib in isolated rat heart fibers and the cardiomyoblast H9c2 cell line. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms23042282","journal-title":"Int J Mol Sci"},{"key":"974_CR9","doi-asserted-by":"publisher","first-page":"e85231","DOI":"10.1371\/journal.pone.0085231","volume":"8","author":"EM Chislock","year":"2013","unstructured":"Chislock EM, Pendergast AM (2013) Abl family kinases regulate endothelial barrier function in vitro and in mice. PLoS ONE 8:e85231. https:\/\/doi.org\/10.1371\/journal.pone.0085231","journal-title":"PLoS ONE"},{"key":"974_CR10","doi-asserted-by":"publisher","first-page":"3502","DOI":"10.1093\/eurheartj\/ehx414","volume":"38","author":"S de Waha","year":"2017","unstructured":"de Waha S, Patel MR, Granger CB, Ohman EM, Maehara A, Eitel I, Ben-Yehuda O, Jenkins P, Thiele H, Stone GW (2017) Relationship between microvascular obstruction and adverse events following primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: an individual patient data pooled analysis from seven randomized trials. Eur Heart J 38:3502\u20133510. https:\/\/doi.org\/10.1093\/eurheartj\/ehx414","journal-title":"Eur Heart J"},{"key":"974_CR11","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1242\/jcs.017897","volume":"121","author":"E Dejana","year":"2008","unstructured":"Dejana E, Orsenigo F, Lampugnani MG (2008) The role of adherens junctions and VE-cadherin in the control of vascular permeability. J Cell Sci 121:2115\u20132122. https:\/\/doi.org\/10.1242\/jcs.017897","journal-title":"J Cell Sci"},{"key":"974_CR12","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1093\/eurheartj\/ehq492","volume":"32","author":"W Desmet","year":"2011","unstructured":"Desmet W, Bogaert J, Dubois C, Sinnaeve P, Adriaenssens T, Pappas C, Ganame J, Dymarkowski S, Janssens S, Belmans A, Van de Werf F (2011) High-dose intracoronary adenosine for myocardial salvage in patients with acute ST-segment elevation myocardial infarction. Eur Heart J 32:867\u2013877. https:\/\/doi.org\/10.1093\/eurheartj\/ehq492","journal-title":"Eur Heart J"},{"key":"974_CR13","doi-asserted-by":"publisher","first-page":"2408","DOI":"10.1056\/NEJMoa062867","volume":"355","author":"BJ Druker","year":"2006","unstructured":"Druker BJ, Guilhot F, O\u2019Brien SG, Gathmann I, Kantarjian H, Gattermann N, Deininger MW, Silver RT, Goldman JM, Stone RM, Cervantes F, Hochhaus A, Powell BL, Gabrilove JL, Rousselot P, Reiffers J, Cornelissen JJ, Hughes T, Agis H, Fischer T, Verhoef G, Shepherd J, Saglio G, Gratwohl A, Nielsen JL, Radich JP, Simonsson B, Taylor K, Baccarani M, So C, Letvak L, Larson RA (2006) Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia. N Engl J Med 355:2408\u20132417. https:\/\/doi.org\/10.1056\/NEJMoa062867","journal-title":"N Engl J Med"},{"key":"974_CR14","doi-asserted-by":"publisher","DOI":"10.1097\/fjc.0000000000001344","author":"E Duijvelaar","year":"2022","unstructured":"Duijvelaar E, Vanhove A, Schippers JR, Smeele PJ, de Man FS, Pinto Y, Aman J, Bogaard HJ (2022) Cardiac safety of imatinib for the treatment of Covid-19: a secondary analysis of a randomised, double blind, placebo-controlled trial. J Cardiovasc Pharmacol. https:\/\/doi.org\/10.1097\/fjc.0000000000001344","journal-title":"J Cardiovasc Pharmacol"},{"key":"974_CR15","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1016\/j.jcmg.2017.11.034","volume":"11","author":"I Eitel","year":"2018","unstructured":"Eitel I, Stiermaier T, Lange T, Rommel KP, Koschalka A, Kowallick JT, Lotz J, Kutty S, Gutberlet M, Hasenfu\u00df G, Thiele H, Schuster A (2018) Cardiac magnetic resonance myocardial feature tracking for optimized prediction of cardiovascular events following myocardial infarction. JACC Cardiovasc Imaging 11:1433\u20131444. https:\/\/doi.org\/10.1016\/j.jcmg.2017.11.034","journal-title":"JACC Cardiovasc Imaging"},{"key":"974_CR16","doi-asserted-by":"publisher","first-page":"537","DOI":"10.3389\/fphys.2018.00537","volume":"9","author":"C Fazakas","year":"2018","unstructured":"Fazakas C, Nagaraj C, Zabini D, V\u00e9gh AG, Marsh LM, Wilhelm I, Krizbai IA, Olschewski H, Olschewski A, B\u00e1lint Z (2018) Rho-kinase inhibition ameliorates dasatinib-induced endothelial dysfunction and pulmonary hypertension. Front Physiol 9:537. https:\/\/doi.org\/10.3389\/fphys.2018.00537","journal-title":"Front Physiol"},{"key":"974_CR17","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1161\/circulationaha.111.049072","volume":"125","author":"A Galaup","year":"2012","unstructured":"Galaup A, Gomez E, Souktani R, Durand M, Cazes A, Monnot C, Teillon J, Le Jan S, Bouleti C, Briois G, Philippe J, Pons S, Martin V, Assaly R, Bonnin P, Ratajczak P, Janin A, Thurston G, Valenzuela DM, Murphy AJ, Yancopoulos GD, Tissier R, Berdeaux A, Ghaleh B, Germain S (2012) Protection against myocardial infarction and no-reflow through preservation of vascular integrity by angiopoietin-like 4. Circulation 125:140\u2013149. https:\/\/doi.org\/10.1161\/circulationaha.111.049072","journal-title":"Circulation"},{"key":"974_CR18","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.jacbts.2022.01.004","volume":"7","author":"T Hamid","year":"2022","unstructured":"Hamid T, Xu Y, Ismahil MA, Rokosh G, Jinno M, Zhou G, Wang Q, Prabhu SD (2022) Cardiac mesenchymal stem cells promote fibrosis and remodeling in heart failure: role of PDGF signaling. JACC Basic Transl Sci 7:465\u2013483. https:\/\/doi.org\/10.1016\/j.jacbts.2022.01.004","journal-title":"JACC Basic Transl Sci"},{"key":"974_CR19","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1093\/cvr\/cvy286","volume":"115","author":"DJ Hausenloy","year":"2019","unstructured":"Hausenloy DJ, Chilian W, Crea F, Davidson SM, Ferdinandy P, Garcia-Dorado D, van Royen N, Schulz R, Heusch G (2019) The coronary circulation in acute myocardial ischaemia\/reperfusion injury: a target for cardioprotection. Cardiovasc Res 115:1143\u20131155. https:\/\/doi.org\/10.1093\/cvr\/cvy286","journal-title":"Cardiovasc Res"},{"key":"974_CR20","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1161\/circresaha.116.308640","volume":"118","author":"G Heusch","year":"2016","unstructured":"Heusch G (2016) The coronary circulation as a target of cardioprotection. Circ Res 118:1643\u20131658. https:\/\/doi.org\/10.1161\/circresaha.116.308640","journal-title":"Circ Res"},{"key":"974_CR21","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/s41569-020-0403-y","volume":"17","author":"G Heusch","year":"2020","unstructured":"Heusch G (2020) Myocardial ischaemia-reperfusion injury and cardioprotection in perspective. Nat Rev Cardiol 17:773\u2013789. https:\/\/doi.org\/10.1038\/s41569-020-0403-y","journal-title":"Nat Rev Cardiol"},{"key":"974_CR22","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1093\/eurheartj\/ehw224","volume":"38","author":"G Heusch","year":"2017","unstructured":"Heusch G, Gersh BJ (2017) The pathophysiology of acute myocardial infarction and strategies of protection beyond reperfusion: a continual challenge. Eur Heart J 38:774\u2013784. https:\/\/doi.org\/10.1093\/eurheartj\/ehw224","journal-title":"Eur Heart J"},{"key":"974_CR23","doi-asserted-by":"publisher","first-page":"e0157233","DOI":"10.1371\/journal.pone.0157233","volume":"11","author":"MR Hollander","year":"2016","unstructured":"Hollander MR, de Waard GA, Konijnenberg LS, Meijer-van Putten RM, van den Brom CE, Paauw N, de Vries HE, van de Ven PM, Aman J, Van Nieuw-Amerongen GP, Hordijk PL, Niessen HW, Horrevoets AJ, Van Royen N (2016) Dissecting the effects of ischemia and reperfusion on the coronary microcirculation in a rat model of acute myocardial infarction. PLoS ONE 11:e0157233. https:\/\/doi.org\/10.1371\/journal.pone.0157233","journal-title":"PLoS ONE"},{"key":"974_CR24","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1093\/cid\/ciab406","volume":"74","author":"KP Hui","year":"2022","unstructured":"Hui KP, Cheung MC, Lai KL, Ng KC, Ho JC, Peiris M, Nicholls JM, Chan MC (2022) Role of epithelial-endothelial cell interaction in the pathogenesis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Clin Infect Dis 74:199\u2013209. https:\/\/doi.org\/10.1093\/cid\/ciab406","journal-title":"Clin Infect Dis"},{"key":"974_CR25","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1001\/jama.2011.522","volume":"305","author":"T Jernberg","year":"2011","unstructured":"Jernberg T, Johanson P, Held C, Svennblad B, Lindb\u00e4ck J, Wallentin L (2011) Association between adoption of evidence-based treatment and survival for patients with ST-elevation myocardial infarction. JAMA 305:1677\u20131684. https:\/\/doi.org\/10.1001\/jama.2011.522","journal-title":"JAMA"},{"key":"974_CR26","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/nm1446","volume":"12","author":"R Kerkel\u00e4","year":"2006","unstructured":"Kerkel\u00e4 R, Grazette L, Yacobi R, Iliescu C, Patten R, Beahm C, Walters B, Shevtsov S, Pesant S, Clubb FJ, Rosenzweig A, Salomon RN, Van Etten RA, Alroy J, Durand JB, Force T (2006) Cardiotoxicity of the cancer therapeutic agent imatinib mesylate. Nat Med 12:908\u2013916. https:\/\/doi.org\/10.1038\/nm1446","journal-title":"Nat Med"},{"key":"974_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/mca.0000000000001058","volume":"31","author":"M Kheifets","year":"2022","unstructured":"Kheifets M, Vaknin-Assa H, Greenberg G, Orvin K, Assali A, Kornowski R, Perl L (2022) Trends in ST-elevation myocardial infarction. Coron Artery Dis 31:1\u20138. https:\/\/doi.org\/10.1097\/mca.0000000000001058","journal-title":"Coron Artery Dis"},{"key":"974_CR28","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s00395-021-00876-6","volume":"116","author":"P Kleinbongard","year":"2021","unstructured":"Kleinbongard P, Andreadou I, Vilahur G (2021) The platelet paradox of injury versus protection in myocardial infarction-has it been overlooked? Basic Res Cardiol 116:37. https:\/\/doi.org\/10.1007\/s00395-021-00876-6","journal-title":"Basic Res Cardiol"},{"key":"974_CR29","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41569-021-00632-2","volume":"19","author":"P Kleinbongard","year":"2022","unstructured":"Kleinbongard P, Heusch G (2022) A fresh look at coronary microembolization. Nat Rev Cardiol 19:265\u2013280. https:\/\/doi.org\/10.1038\/s41569-021-00632-2","journal-title":"Nat Rev Cardiol"},{"key":"974_CR30","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1016\/j.toxrep.2021.05.008","volume":"8","author":"M Kobara","year":"2021","unstructured":"Kobara M, Nessa N, Toba H, Nakata T (2021) Induction of autophagy has protective roles in imatinib-induced cardiotoxicity. Toxicol Rep 8:1087\u20131097. https:\/\/doi.org\/10.1016\/j.toxrep.2021.05.008","journal-title":"Toxicol Rep"},{"key":"974_CR31","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1161\/01.RES.0000218193.51136.ad","volume":"98","author":"N Kogata","year":"2006","unstructured":"Kogata N, Arai Y, Pearson JT, Hashimoto K, Hidaka K, Koyama T, Somekawa S, Nakaoka Y, Ogawa M, Adams RH, Okada M, Mochizuki N (2006) Cardiac ischemia activates vascular endothelial cadherin promoter in both preexisting vascular cells and bone marrow cells involved in neovascularization. Circ Res 98:897\u2013904. https:\/\/doi.org\/10.1161\/01.RES.0000218193.51136.ad","journal-title":"Circ Res"},{"key":"974_CR32","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1093\/cvr\/cvz301","volume":"116","author":"LSF Konijnenberg","year":"2020","unstructured":"Konijnenberg LSF, Damman P, Duncker DJ, Kloner RA, Nijveldt R, van Geuns RM, Berry C, Riksen NP, Escaned J, van Royen N (2020) Pathophysiology and diagnosis of coronary microvascular dysfunction in ST-elevation myocardial infarction. Cardiovasc Res 116:787\u2013805. https:\/\/doi.org\/10.1093\/cvr\/cvz301","journal-title":"Cardiovasc Res"},{"key":"974_CR33","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1016\/j.bja.2017.11.095","volume":"120","author":"NJ Koning","year":"2018","unstructured":"Koning NJ, de Lange F, van Meurs M, Jongman RM, Ahmed Y, Schwarte LA, van Nieuw Amerongen GP, Vonk ABA, Niessen HW, Baufreton C, Boer C (2018) Reduction of vascular leakage by imatinib is associated with preserved microcirculatory perfusion and reduced renal injury markers in a rat model of cardiopulmonary bypass. Br J Anaesth 120:1165\u20131175. https:\/\/doi.org\/10.1016\/j.bja.2017.11.095","journal-title":"Br J Anaesth"},{"key":"974_CR34","doi-asserted-by":"publisher","first-page":"8555","DOI":"10.1096\/fj.201900060R","volume":"33","author":"Y Li","year":"2019","unstructured":"Li Y, Yao Y, Li J, Chen Q, Zhang L, Wang QK (2019) Losartan protects against myocardial ischemia and reperfusion injury via vascular integrity preservation. Faseb j 33:8555\u20138564. https:\/\/doi.org\/10.1096\/fj.201900060R","journal-title":"Faseb j"},{"key":"974_CR35","doi-asserted-by":"publisher","DOI":"10.1007\/s10557-022-07345-9","author":"HR Lieder","year":"2022","unstructured":"Lieder HR, Tsoumani M, Andreadou I, Schr\u00f6r K, Heusch G, Kleinbongard P (2022) Platelet-mediated transfer of cardioprotection by remote ischemic conditioning and its abrogation by aspirin but not by ticagrelor. Cardiovasc Drugs Ther. https:\/\/doi.org\/10.1007\/s10557-022-07345-9","journal-title":"Cardiovasc Drugs Ther"},{"key":"974_CR36","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.jacc.2021.10.034","volume":"79","author":"T Liu","year":"2022","unstructured":"Liu T, Howarth AG, Chen Y, Nair AR, Yang HJ, Ren D, Tang R, Sykes J, Kovacs MS, Dey D, Slomka P, Wood JC, Finney R, Zeng M, Prato FS, Francis J, Berman DS, Shah PK, Kumar A, Dharmakumar R (2022) Intramyocardial hemorrhage and the \u201cwave front\u201d of reperfusion injury compromising myocardial salvage. J Am Coll Cardiol 79:35\u201348. https:\/\/doi.org\/10.1016\/j.jacc.2021.10.034","journal-title":"J Am Coll Cardiol"},{"key":"974_CR37","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1016\/j.athoracsur.2017.10.002","volume":"105","author":"JT Magruder","year":"2018","unstructured":"Magruder JT, Grimm JC, Crawford TC, Johnston L, Santhanam L, Stephens RS, Berkowitz DE, Shah AS, Bush EL, Damarla M, Damico RL, Hassoun PM, Kim BS (2018) Imatinib is protective against ischemia-reperfusion injury in an ex vivo rabbit model of lung injury. Ann Thorac Surg 105:950\u2013956. https:\/\/doi.org\/10.1016\/j.athoracsur.2017.10.002","journal-title":"Ann Thorac Surg"},{"key":"974_CR38","doi-asserted-by":"publisher","first-page":"630480","DOI":"10.3389\/fcvm.2020.630480","volume":"7","author":"CJ McMullen","year":"2020","unstructured":"McMullen CJ, Chalmers S, Wood R, Cunningham MR, Currie S (2020) Sunitinib and imatinib display differential cardiotoxicity in adult rat cardiac fibroblasts that involves a role for calcium\/calmodulin dependent protein kinase II. Front Cardiovasc Med 7:630480. https:\/\/doi.org\/10.3389\/fcvm.2020.630480","journal-title":"Front Cardiovasc Med"},{"key":"974_CR39","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s12975-014-0358-6","volume":"6","author":"Z Merali","year":"2015","unstructured":"Merali Z, Leung J, Mikulis D, Silver F, Kassner A (2015) Longitudinal assessment of imatinib\u2019s effect on the blood-brain barrier after ischemia\/reperfusion injury with permeability MRI. Transl Stroke Res 6:39\u201349. https:\/\/doi.org\/10.1007\/s12975-014-0358-6","journal-title":"Transl Stroke Res"},{"key":"974_CR40","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4103\/0976-0105.177703","volume":"7","author":"AB Nair","year":"2016","unstructured":"Nair AB, Jacob S (2016) A simple practice guide for dose conversion between animals and human. J Basic Clin Pharm 7:27\u201331. https:\/\/doi.org\/10.4103\/0976-0105.177703","journal-title":"J Basic Clin Pharm"},{"key":"974_CR41","doi-asserted-by":"publisher","first-page":"e0243207","DOI":"10.1371\/journal.pone.0243207","volume":"15","author":"AR Nair","year":"2020","unstructured":"Nair AR, Johnson EA, Yang HJ, Cokic I, Francis J, Dharmakumar R (2020) Reperfused hemorrhagic myocardial infarction in rats. PLoS ONE 15:e0243207. https:\/\/doi.org\/10.1371\/journal.pone.0243207","journal-title":"PLoS ONE"},{"key":"974_CR42","doi-asserted-by":"publisher","first-page":"507","DOI":"10.14670\/hh-11-952","volume":"33","author":"A Nakano-Doi","year":"2018","unstructured":"Nakano-Doi A, Sakuma R, Matsuyama T, Nakagomi T (2018) Ischemic stroke activates the VE-cadherin promoter and increases VE-cadherin expression in adult mice. Histol Histopathol 33:507\u2013521. https:\/\/doi.org\/10.14670\/hh-11-952","journal-title":"Histol Histopathol"},{"key":"974_CR43","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1093\/eurheartj\/ehw136","volume":"37","author":"SA Nazir","year":"2016","unstructured":"Nazir SA, McCann GP, Greenwood JP, Kunadian V, Khan JN, Mahmoud IZ, Blackman DJ, Been M, Abrams KR, Shipley L, Wilcox R, Adgey AA, Gershlick AH (2016) Strategies to attenuate micro-vascular obstruction during P-PCI: the randomized reperfusion facilitated by local adjunctive therapy in ST-elevation myocardial infarction trial. Eur Heart J 37:1910\u20131919. https:\/\/doi.org\/10.1093\/eurheartj\/ehw136","journal-title":"Eur Heart J"},{"key":"974_CR44","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1161\/circresaha.119.315344","volume":"125","author":"G Niccoli","year":"2019","unstructured":"Niccoli G, Montone RA, Ibanez B, Thiele H, Crea F, Heusch G, Bulluck H, Hausenloy DJ, Berry C, Stiermaier T, Camici PG, Eitel I (2019) Optimized treatment of ST-elevation myocardial infarction. Circ Res 125:245\u2013258. https:\/\/doi.org\/10.1161\/circresaha.119.315344","journal-title":"Circ Res"},{"key":"974_CR45","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.ejps.2018.01.007","volume":"115","author":"S Notenboom","year":"2018","unstructured":"Notenboom S, Weigand KM, Proost JH, van Lipzig MMH, van de Steeg E, van den Broek PHH, Greupink R, Russel FGM, Groothuis GMM (2018) Development of a mechanistic biokinetic model for hepatic bile acid handling to predict possible cholestatic effects of drugs. Eur J Pharm Sci 115:175\u2013184. https:\/\/doi.org\/10.1016\/j.ejps.2018.01.007","journal-title":"Eur J Pharm Sci"},{"key":"974_CR46","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1056\/NEJMoa022457","volume":"348","author":"SG O'Brien","year":"2003","unstructured":"O\u2019Brien SG, Guilhot F, Larson RA, Gathmann I, Baccarani M, Cervantes F, Cornelissen JJ, Fischer T, Hochhaus A, Hughes T, Lechner K, Nielsen JL, Rousselot P, Reiffers J, Saglio G, Shepherd J, Simonsson B, Gratwohl A, Goldman JM, Kantarjian H, Taylor K, Verhoef G, Bolton AE, Capdeville R, Druker BJ (2003) Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia. N Engl J Med 348:994\u20131004. https:\/\/doi.org\/10.1056\/NEJMoa022457","journal-title":"N Engl J Med"},{"key":"974_CR47","doi-asserted-by":"publisher","first-page":"H1288","DOI":"10.1152\/ajpheart.00329.2013","volume":"305","author":"EA Pankey","year":"2013","unstructured":"Pankey EA, Thammasiboon S, Lasker GF, Baber S, Lasky JA, Kadowitz PJ (2013) Imatinib attenuates monocrotaline pulmonary hypertension and has potent vasodilator activity in pulmonary and systemic vascular beds in the rat. Am J Physiol Heart Circ Physiol 305:H1288-1296. https:\/\/doi.org\/10.1152\/ajpheart.00329.2013","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"974_CR48","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1161\/circresaha.116.303577","volume":"119","author":"SD Prabhu","year":"2016","unstructured":"Prabhu SD, Frangogiannis NG (2016) The biological basis for cardiac repair after myocardial infarction: from inflammation to fibrosis. Circ Res 119:91\u2013112. https:\/\/doi.org\/10.1161\/circresaha.116.303577","journal-title":"Circ Res"},{"key":"974_CR49","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1161\/atvbaha.115.305085","volume":"35","author":"AN Rizzo","year":"2015","unstructured":"Rizzo AN, Aman J, van Nieuw Amerongen GP, Dudek SM (2015) Targeting Abl kinases to regulate vascular leak during sepsis and acute respiratory distress syndrome. Arterioscler Thromb Vasc Biol 35:1071\u20131079. https:\/\/doi.org\/10.1161\/atvbaha.115.305085","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"974_CR50","doi-asserted-by":"publisher","first-page":"2346","DOI":"10.1093\/eurheartj\/eht100","volume":"34","author":"LF Robbers","year":"2013","unstructured":"Robbers LF, Eerenberg ES, Teunissen PF, Jansen MF, Hollander MR, Horrevoets AJ, Knaapen P, Nijveldt R, Heymans MW, Levi MM, van Rossum AC, Niessen HW, Marcu CB, Beek AM, van Royen N (2013) Magnetic resonance imaging-defined areas of microvascular obstruction after acute myocardial infarction represent microvascular destruction and haemorrhage. Eur Heart J 34:2346\u20132353. https:\/\/doi.org\/10.1093\/eurheartj\/eht100","journal-title":"Eur Heart J"},{"key":"974_CR51","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s12967-019-1881-8","volume":"17","author":"AA Sayour","year":"2019","unstructured":"Sayour AA, Korkmaz-Ic\u00f6z S, Loganathan S, Ruppert M, Sayour VN, Ol\u00e1h A, Benke K, Brune M, Benk\u0151 R, Horv\u00e1th EM, Karck M, Merkely B, Radovits T, Szab\u00f3 G (2019) Acute canagliflozin treatment protects against in vivo myocardial ischemia-reperfusion injury in non-diabetic male rats and enhances endothelium-dependent vasorelaxation. J Transl Med 17:127. https:\/\/doi.org\/10.1186\/s12967-019-1881-8","journal-title":"J Transl Med"},{"key":"974_CR52","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, Preibisch S, Rueden C, Saalfeld S, Schmid B, Tinevez JY, White DJ, Hartenstein V, Eliceiri K, Tomancak P, Cardona A (2012) Fiji: an open-source platform for biological-image analysis. Nat Methods 9:676\u2013682. https:\/\/doi.org\/10.1038\/nmeth.2019","journal-title":"Nat Methods"},{"key":"974_CR53","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1083\/jcb.30.2.424","volume":"30","author":"AM Seligman","year":"1966","unstructured":"Seligman AM, Wasserkrug HL, Hanker JS (1966) A new staining method (OTO) for enhancing contrast of lipid\u2013containing membranes and droplets in osmium tetroxide\u2013fixed tissue with osmiophilic thiocarbohydrazide(TCH). J Cell Biol 30:424\u2013432. https:\/\/doi.org\/10.1083\/jcb.30.2.424","journal-title":"J Cell Biol"},{"key":"974_CR54","doi-asserted-by":"publisher","first-page":"C559","DOI":"10.1152\/ajpcell.00375.2012","volume":"306","author":"RS Stephens","year":"2014","unstructured":"Stephens RS, Servinsky LE, Rentsendorj O, Kolb TM, Pfeifer A, Pearse DB (2014) Protein kinase G increases antioxidant function in lung microvascular endothelial cells by inhibiting the c-Abl tyrosine kinase. Am J Physiol Cell Physiol 306:C559-569. https:\/\/doi.org\/10.1152\/ajpcell.00375.2012","journal-title":"Am J Physiol Cell Physiol"},{"key":"974_CR55","doi-asserted-by":"publisher","first-page":"2218","DOI":"10.1056\/NEJMoa0708191","volume":"358","author":"GW Stone","year":"2008","unstructured":"Stone GW, Witzenbichler B, Guagliumi G, Peruga JZ, Brodie BR, Dudek D, Kornowski R, Hartmann F, Gersh BJ, Pocock SJ, Dangas G, Wong SC, Kirtane AJ, Parise H, Mehran R (2008) Bivalirudin during primary PCI in acute myocardial infarction. N Engl J Med 358:2218\u20132230. https:\/\/doi.org\/10.1056\/NEJMoa0708191","journal-title":"N Engl J Med"},{"key":"974_CR56","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/nm1787","volume":"14","author":"EJ Su","year":"2008","unstructured":"Su EJ, Fredriksson L, Geyer M, Folestad E, Cale J, Andrae J, Gao Y, Pietras K, Mann K, Yepes M, Strickland DK, Betsholtz C, Eriksson U, Lawrence DA (2008) Activation of PDGF-CC by tissue plasminogen activator impairs blood-brain barrier integrity during ischemic stroke. Nat Med 14:731\u2013737. https:\/\/doi.org\/10.1038\/nm1787","journal-title":"Nat Med"},{"key":"974_CR57","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1016\/j.athoracsur.2016.05.037","volume":"102","author":"S Tanaka","year":"2016","unstructured":"Tanaka S, Chen-Yoshikawa TF, Kajiwara M, Menju T, Ohata K, Takahashi M, Kondo T, Hijiya K, Motoyama H, Aoyama A, Masuda S, Date H (2016) Protective Effects of Imatinib on Ischemia\/Reperfusion Injury in Rat Lung. Ann Thorac Surg 102:1717\u20131724. https:\/\/doi.org\/10.1016\/j.athoracsur.2016.05.037","journal-title":"Ann Thorac Surg"},{"key":"974_CR58","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/nprot.2011.439","volume":"7","author":"JC Tapia","year":"2012","unstructured":"Tapia JC, Kasthuri N, Hayworth KJ, Schalek R, Lichtman JW, Smith SJ, Buchanan J (2012) High-contrast en bloc staining of neuronal tissue for field emission scanning electron microscopy. Nat Protoc 7:193\u2013206. https:\/\/doi.org\/10.1038\/nprot.2011.439","journal-title":"Nat Protoc"},{"key":"974_CR59","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1002\/cncr.24683","volume":"116","author":"JC Trent","year":"2010","unstructured":"Trent JC, Patel SS, Zhang J, Araujo DM, Plana JC, Lenihan DJ, Fan D, Patel SR, Benjamin RS, Khakoo AY (2010) Rare incidence of congestive heart failure in gastrointestinal stromal tumor and other sarcoma patients receiving imatinib mesylate. Cancer 116:184\u2013192. https:\/\/doi.org\/10.1002\/cncr.24683","journal-title":"Cancer"},{"key":"974_CR60","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1093\/cvr\/cvz004","volume":"115","author":"L Uthman","year":"2019","unstructured":"Uthman L, Nederlof R, Eerbeek O, Baartscheer A, Schumacher C, Buchholtz N, Hollmann MW, Coronel R, Weber NC, Zuurbier CJ (2019) Delayed ischaemic contracture onset by empagliflozin associates with NHE1 inhibition and is dependent on insulin in isolated mouse hearts. Cardiovasc Res 115:1533\u20131545. https:\/\/doi.org\/10.1093\/cvr\/cvz004","journal-title":"Cardiovasc Res"},{"key":"974_CR61","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.jcmg.2014.05.010","volume":"7","author":"M van Kranenburg","year":"2014","unstructured":"van Kranenburg M, Magro M, Thiele H, de Waha S, Eitel I, Cochet A, Cottin Y, Atar D, Buser P, Wu E, Lee D, Bodi V, Klug G, Metzler B, Delewi R, Bernhardt P, Rottbauer W, Boersma E, Zijlstra F, van Geuns RJ (2014) Prognostic value of microvascular obstruction and infarct size, as measured by CMR in STEMI patients. JACC Cardiovasc Imaging 7:930\u2013939. https:\/\/doi.org\/10.1016\/j.jcmg.2014.05.010","journal-title":"JACC Cardiovasc Imaging"},{"key":"974_CR62","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1136\/hrt.2005.075077","volume":"92","author":"K Vijayalakshmi","year":"2006","unstructured":"Vijayalakshmi K, Whittaker VJ, Kunadian B, Graham J, Wright RA, Hall JA, Sutton A, de Belder MA (2006) Prospective, randomised, controlled trial to study the effect of intracoronary injection of verapamil and adenosine on coronary blood flow during percutaneous coronary intervention in patients with acute coronary syndromes. Heart 92:1278\u20131284. https:\/\/doi.org\/10.1136\/hrt.2005.075077","journal-title":"Heart"},{"key":"974_CR63","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1016\/j.leukres.2010.01.004","volume":"34","author":"A Wolf","year":"2010","unstructured":"Wolf A, Couttet P, Dong M, Grenet O, Heron M, Junker U, Laengle U, Ledieu D, Marrer E, Nussher A, Persohn E, Pognan F, Rivi\u00e8re GJ, Roth DR, Trendelenburg C, Tsao J, Roman D (2010) Imatinib does not induce cardiotoxicity at clinically relevant concentrations in preclinical studies. Leuk Res 34:1180\u20131188. https:\/\/doi.org\/10.1016\/j.leukres.2010.01.004","journal-title":"Leuk Res"},{"key":"974_CR64","doi-asserted-by":"publisher","first-page":"647","DOI":"10.3348\/kjr.2019.0853","volume":"21","author":"Z Xu","year":"2020","unstructured":"Xu Z, Chen W, Zhang R, Wang L, Chen R, Zheng J, Gao F (2020) Human recombinant apyrase therapy protects against myocardial ischemia\/reperfusion injury and preserves left ventricular systolic function in rats, as evaluated by 7T cardiovascular magnetic resonance imaging. Korean J Radiol 21:647\u2013659. https:\/\/doi.org\/10.3348\/kjr.2019.0853","journal-title":"Korean J Radiol"}],"container-title":["Basic Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00395-022-00974-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00395-022-00974-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00395-022-00974-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T14:03:44Z","timestamp":1702649024000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00395-022-00974-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,13]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["974"],"URL":"https:\/\/doi.org\/10.1007\/s00395-022-00974-z","relation":{},"ISSN":["1435-1803"],"issn-type":[{"value":"1435-1803","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,13]]},"assertion":[{"value":"5 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The manuscript does not contain clinical studies or patient data. Animal experiments are performed conform the guidelines from Directive 2010\/63\/EU of the European Parliament and reported according to the ARRIVE guidelines.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"2"}}